(Q39064354)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24217810%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

title

Rationally designed capsid and transgene cassette of AAV6 vectors for dendritic cell-based cancer immunotherapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24217810%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1 reference

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24217810%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Chen Ling

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24217810%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

George Aslanidi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24217810%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

author name string

Jheel Pandya

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24217810%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Luis Ortiz

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24217810%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

publication date

12 November 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24217810%20AND%20SRC:MED&resulttype=core&format=json

Immunology & Cell Biology

29 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24217810%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

volume

92

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24217810%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24217810%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

page(s)

116-123

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24217810%20AND%20SRC:MED&resulttype=core&format=json

Recent developments in cancer vaccines

29 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.74

Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.74

Dendritic cells and the control of immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.74

Dendritic cell immunotherapy: mapping the way.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.74

Role of vaccine therapy in cancer: biology and practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.74

Harnessing human dendritic cell subsets for medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.74

Targeting human dendritic cell subsets for improved vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.74

Viral and non-viral methods to genetically modify dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.74

The AAV vector toolkit: poised at the clinical crossroads

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.74

Gene therapy using adeno-associated virus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.74

rAAV human trial experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.74

Adeno-associated virus-mediated gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.74

Tyrosine-phosphorylation of AAV2 vectors and its consequences on viral intracellular trafficking and transgene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.74

High-efficiency transduction of human monocyte-derived dendritic cells by capsid-modified recombinant AAV2 vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.74

High-efficiency transduction and correction of murine hemophilia B using AAV2 vectors devoid of multiple surface-exposed tyrosines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.74

High-efficiency transduction of the mouse retina by tyrosine-mutant AAV serotype vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.74

Next generation of adeno-associated virus 2 vectors: point mutations in tyrosines lead to high-efficiency transduction at lower doses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.74

Development of optimized AAV3 serotype vectors: mechanism of high-efficiency transduction of human liver cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.74

Promoters and control elements: designing expression cassettes for gene therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.74

Adeno-associated virus terminal repeat (TR) mutant generates self-complementary vectors to overcome the rate-limiting step to transduction in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.74

Comparative promoter analysis in vivo: identification of a dendritic cell-specific promoter module

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.74

Targeting anti-tumor DNA vaccines to dendritic cells via a short CD11c promoter sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.74

Optimization of the capsid of recombinant adeno-associated virus 2 (AAV2) vectors: the final threshold?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.74

Adeno-associated virus type 2-mediated transduction of human monocyte-derived dendritic cells: implications for ex vivo immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.74

Effective transduction by self-complementary adeno-associated viruses of human dendritic cells with no alteration of their natural characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.74

Optimized transduction of human monocyte-derived dendritic cells by recombinant adeno-associated virus serotype 6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.74

Major subsets of human dendritic cells are efficiently transduced by self-complementary adeno-associated virus vectors 1 and 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.74

Induction of an antitumoral immune response by wild-type adeno-associated virus type 2 in an in vivo model of pancreatic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.74

Generation of robust cytotoxic T lymphocytes against prostate specific antigen by transduction of dendritic cells using protein and recombinant adeno-associated virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.74

rAAV/Her-2/neu loading of dendritic cells for a potent cellular-mediated MHC class I restricted immune response against ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.74

Single amino acid modification of adeno-associated virus capsid changes transduction and humoral immune profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.74

Custom adeno-associated virus capsids: the next generation of recombinant vectors with novel tropism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.74

Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.74

Single amino acid changes can influence titer, heparin binding, and tissue tropism in different adeno-associated virus serotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.74

Targeting photoreceptors via intravitreal delivery using novel, capsid-mutated AAV vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.74

Enhanced transduction of mouse bone marrow-derived dendritic cells by repetitive infection with self-complementary adeno-associated virus 6 combined with immunostimulatory ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.74

Structural Characterization of the Dual Glycan Binding Adeno-Associated Virus Serotype 6

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.74

Structure–function analysis of receptor-binding in adeno-associated virus serotype 6 (AAV-6)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.74

Optimizing the transduction efficiency of capsid-modified AAV6 serotype vectors in primary human hematopoietic stem cells in vitro and in a xenograft mouse model in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.74

High-efficiency transduction of primary human hematopoietic stem cells and erythroid lineage-restricted expression by optimized AAV6 serotype vectors in vitro and in a murine xenograft model in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.74

Monocyte-derived DC maturation strategies and related pathways: a transcriptional view

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.74

Rapid and highly efficient transduction by double-stranded adeno-associated virus vectors in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.74

Design and construction of functional AAV vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.74

Transcription factors in the control of dendritic cell life cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.74

Development of monocytes, macrophages, and dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.74

Production and purification of serotype 1, 2, and 5 recombinant adeno-associated viral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.74

Limitations of encapsidation of recombinant self-complementary adeno-associated viral genomes in different serotype capsids and their quantitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.74

A methodological framework to enhance the clinical success of cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.74

Analyzing cytotoxic T lymphocyte activity: a simple and reliable flow cytometry-based assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.74